ProQR Therapeutics N.V.

NASDAQ: PRQR · Real-Time Price · USD
2.04
0.02 (0.99%)
At close: Aug 15, 2025, 3:59 PM
2.05
0.24%
After-hours: Aug 15, 2025, 04:10 PM EDT

ProQR Therapeutics Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
18.91M 6.51M 4.04M 1.35M
Cost of Revenue
n/a 133.52K 2.48M n/a
Gross Profit
18.91M 6.38M 1.56M 1.35M
Operating Income
-30.47M -31.86M -64.72M -57.19M
Interest Income
3.25M 2.59M 106K 5K
Pretax Income
-27.96M -27.81M -64.8M -61.56M
Net Income
-27.76M -28.12M -64.89M -61.68M
Selling & General & Admin
13.66M 16.24M 18.65M 17.37M
Research & Development
36.36M 25.15M 50.87M 42.22M
Other Expenses
-640K -3.01M -765K -1.04M
Operating Expenses
49.38M 38.37M 68.75M 58.55M
Interest Expense
1.08M 1.2M 5.13M 3.4M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
49.38M 38.37M 68.75M 58.55M
Income Tax Expense
-197K -78K 96K 117K
Shares Outstanding (Basic)
81.67M 81.01M 71.64M 64.18M
Shares Outstanding (Diluted)
81.67M 81.01M 71.64M 64.18M
EPS (Basic)
-0.34 -0.35 -0.91 -0.96
EPS (Diluted)
-0.34 -0.35 -0.91 -0.96
EBITDA
-24.12M -24.1M -56.46M -54.95M
EBIT
-26.88M -26.61M -58.98M -57.28M
Depreciation & Amortization
2.76M 2.51M 2.48M 2.42M